¼¼°èÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå(2025³â)
Fetal Monitoring Global Market Report 2025
»óǰÄÚµå : 1667725
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,151,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,891,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,632,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 9.1%ÀÇ CAGR·Î È®´ëÇϸç, 2029³â¿¡´Â 57¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ ÁßÀÇ ¼ºÀåÀº °íÀ§Çè ÀӽŠÁõ°¡, ¿ø°ÝÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ µ¿Çâ, ºñħ½ÀÀû ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÁýÁß, ¿¬±¸°³¹ßÀ» À§ÇÑ Çù¾÷, Ãâ»ê °ü¸®ÀÇ È¯ÀÚ Áß½ÉÀû Á¢±Ù ¹æ½Ä¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀº ¹«¼± ¹× ¿þ¾î·¯ºí ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±â, ÅÂ¾Æ ¸ð´ÏÅ͸µ¿¡ ÀΰøÁö´É(AI) ÅëÇÕ, ¿ø°Ý ÅÂ¾Æ ¸ð´ÏÅ͸µ ¼­ºñ½º, ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼ú, ÈÞ´ë¿ë ¹× ÇÚµåÇïµå ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ÁýÁß, ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼ú¿¡ ´ëÇÑ °ü½É µîÀÔ´Ï´Ù.

ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀº ÁÖ·Î Á¶»êÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀӽŠ37ÁÖ ÀÌÀü¿¡ ¹ß»ýÇÏ´Â Á¶»êÀº ¿µÀ¯¾ÆÀÇ »ç¸Á·ü°ú Àå¾Ö¿ÍÀÇ ¿¬°ü¼ºÀ¸·Î ÀÎÇØ ½É°¢ÇÑ ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº ÅÂ¾Æ ¸ð´ÏÅ͸µ Àåºñ¸¦ ÅëÇØ žÆÀÇ ½É¹Ú¼ö, »ê¸ðÀÇ ÁøÅë°ú °°Àº ÆÄ¶ó¹ÌÅ͸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ºÐ¸¸½Ã Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. Á¶»êÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø ¹× Ŭ¸®´ÐÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 11¿ù ÇöÀç, ¼¼°èº¸°Ç±â±¸(WHO)´Â ¿¬°£ ÃßÁ¤ 1,500¸¸ °ÇÀÇ Á¶»êÀ» º¸°íÇϰí ÀÖÀ¸¸ç, ½Å»ý¾Æ 10¸í´ç 1¸í ÀÌ»óÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î Á¶»êÀÇ À¯ÇàÀº ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÇコÄɾ ´ëÇÑ ÁöÃâ Áõ°¡´Â ÇâÈÄ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇコÄɾî ÁöÃâÀº ±¹°¡, Á¤ºÎ, Á¶Á÷ ¶Ç´Â °³ÀÎÀÌ ÇコÄÉ¾î °ü·Ã Á¦Ç° ¹× ¼­ºñ½º¿¡ ÇÒ´çÇÏ´Â ÃÑ ÀÚ¿ø(ÀçÁ¤Àû ¹× ºñÀçÁ¤Àû)À» Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁöÃâ Áõ°¡´Â ±â¼ú ¹ßÀüÀ» ÃËÁøÇϰí, Á¢±Ù¼ºÀ» °³¼±Çϰí, ¿¬±¸°³¹ß ±¸»óÀ» Áö¿øÇϰí, ¸ð¼º ¹× ÅÂ¾Æ ÀÇ·áÀÇ Àü¹ÝÀûÀΠǰÁú Çâ»óÀ» ÃËÁøÇÔÀ¸·Î½á ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 12¿ù, ¹Ì±¹ÀÇ ¿¬¹æ ±â°üÀÎ Centers for Medicare & Medicaid Services´Â 2022³â ÀÇ·á ÁöÃâÀÌ 4.1% Áõ°¡Çϸç, 4Á¶ 5,000¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2021³âÀÇ 3.2% Áõ°¡¸¦ ¿ôµ·´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú, ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀ» ¹ßÀü½ÃŰ´Â Áß¿äÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í Á¦Ç°º°, ¹æ¹ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ª¡¤±¹°¡º° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Covid¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦9Àå Áß±¹ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦10Àå ÀεµÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦11Àå ÀϺ»ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦12Àå È£ÁÖÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦14Àå Çѱ¹ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦15Àå ¼­À¯·´ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦16Àå ¿µ±¹ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦17Àå µ¶ÀÏÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦18Àå ÇÁ¶û½ºÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾ÆÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦20Àå ½ºÆäÀÎÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦21Àå µ¿À¯·´ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦22Àå ·¯½Ã¾ÆÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦23Àå ºÏ¹Ì ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦24Àå ¹Ì±¹ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦25Àå ij³ª´ÙÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦26Àå ³²¹ÌÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦27Àå ºê¶óÁúÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦28Àå Áßµ¿ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä«ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå

Á¦30Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ±âŸ ´ëÇü ¹× Çõ½ÅÀû ±â¾÷

Á¦32Àå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù µ¿Çâ

Á¦35Àå ÀáÀçÀû °¡´É¼ºÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Fetal monitoring involves the utilization of specialized equipment by medical professionals to monitor both the mother's contractions and the fetus's heart rate during the birthing process. This monitoring process provides crucial information that guides medical professionals in determining whether intervention is necessary during childbirth.

The primary product categories within fetal monitoring encompass ultrasound devices, electronic maternal or fetal monitors, uterine contraction monitors, fetal electrodes, fetal Doppler devices, telemetry devices, as well as accessories and consumables. Ultrasound devices, a form of medical imaging technology, generate images of the body's interior using high-frequency sound waves. These services employ both invasive and non-invasive methods and find applications in intrapartum fetal monitoring, antepartum fetal monitoring, and are utilized by end-users such as diagnostic laboratories, hospitals, clinics, and other healthcare facilities.

The fetal monitoring market research report is one of a series of new reports from The Business Research Company that provides fetal monitoring optical components market statistics, including fetal monitoring optical components industry global market size, regional shares, competitors with a fetal monitoring optical components market share, detailed fetal monitoring optical components market segments, market trends and opportunities, and any further data you may need to thrive in the fetal monitoring optical components industry. This fetal monitoring optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fetal monitoring market size has grown strongly in recent years. It will grow from$3.8 billion in 2024 to $4.08 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing maternal age, high prevalence of pregnancy complications, rising awareness and emphasis on prenatal care, government initiatives for maternal and child health, and increasing cesarean section rates

The fetal monitoring market size is expected to see strong growth in the next few years. It will grow to $5.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to a rise in high-risk pregnancies, telehealth and remote monitoring trends, focus on non-invasive monitoring solutions, collaborations for research and development, patient-centric approach in maternity care. Major trends in the forecast period include wireless and wearable fetal monitoring devices, integration of artificial intelligence (AI) in fetal monitoring, remote fetal monitoring services, focus on non-invasive monitoring technologies, and portable and handheld fetal monitoring devices.

The fetal monitoring market is poised for growth, primarily propelled by the increasing prevalence of preterm births. Preterm births, occurring before the 37th week of pregnancy, are a significant concern due to their association with infant mortality and disability. Healthcare providers utilize fetal monitoring devices to continuously monitor parameters such as fetal heart rate and the mother's contractions, enabling timely interventions during delivery. The demand for fetal monitoring devices in hospitals and clinics is on the rise with the increasing occurrence of preterm deliveries. For example, as of November 2022, the World Health Organization reported an estimated 15 million premature births annually, accounting for over one in ten newborns. Consequently, the prevalence of preterm births acts as a driving force for the growth of the fetal monitoring market.

The increasing expenditure on healthcare is anticipated to accelerate the expansion of the fetal monitoring market in the future. Healthcare expenditure encompasses the total resources-both financial and non-financial-allocated by a country, government, organization, or individual towards healthcare-related products and services. This rising expenditure plays a vital role in the growth of the fetal monitoring market by facilitating technological advancements, enhancing accessibility, supporting research and development initiatives, and driving overall improvements in maternal and fetal healthcare quality. For example, in December 2022, the Centers for Medicare & Medicaid Services, a federal agency in the U.S., reported a 4.1% increase in healthcare spending, reaching $4.5 trillion in 2022, outpacing the 3.2% growth seen in 2021. Consequently, the growing healthcare expenditure is a key factor propelling the fetal monitoring market forward.

Major companies within the fetal monitoring market are at the forefront of developing cutting-edge technologies, such as AI-based fetal assessment platforms, aiming to cater to larger customer bases, boost sales, and increase revenue. An AI-based fetal assessment platform utilizes artificial intelligence (AI) algorithms and computational techniques to analyze and interpret data related to fetal well-being during pregnancy. For example, in August 2023, PeriGen Inc., a US-based provider of perinatal software solutions, introduced the LaborWatch platform. Distinguished as a groundbreaking platform, LaborWatch enhances intrapartum patient safety by promptly and transparently alerting hospital leadership to persistent deteriorating trends in laboring patients. Fueled by PeriWatch Vigilance, the exclusive AI-based maternal-fetal early warning system in the United States, LaborWatch autonomously identifies abnormal patient conditions and communicates notifications to the chain of command within a predefined timeframe. This streamlined process ensures that hospital leaders are promptly informed about critical situations, setting LaborWatch apart with its unique and effective approach.

Major companies in the fetal monitoring market are adopting a strategic partnership approach to offer a more comprehensive pregnancy care experience, spanning from the prenatal phase through labor and delivery. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. In March 2022, Royal Philips, a Netherlands-based provider of fetal monitoring solutions, formed a partnership with Nuvo Group Ltd., an Israel-based provider of medical devices. This collaboration involves Philips assisting Nuvo in conducting pilot programs for remote fetal monitoring to enhance accessibility and adherence to prescribed care, starting with a pilot program in rural Colorado. This partnership signifies Nuvo's commitment to delivering more comprehensive pregnancy care solutions to patients, providers, and payers.

In July 2022, Archimed SAS, a private equity firm based in France, purchased Natus Medical Incorporated for $1.1 billion. This acquisition is intended to strengthen Archimed SAS's portfolio by incorporating Natus Medical's knowledge in neurodiagnostics and neurology solutions, thereby broadening their healthcare technology capabilities. Natus Medical Incorporated, a medical device company located in the United States, provides an extensive array of products and services centered around neurodiagnostic, newborn care, and hearing screening solutions for healthcare professionals.

Major companies operating in the fetal monitoring market include Koninklijke Philips N.V., Medtronic plc, Siemens Healthineers AG, GE Healthcare Company, Neoventa Medical AB, Spacelabs Healthcare Inc., Natus Medical Incorporated, EDAN Instruments Inc., Shenzhen Comen Medical Instruments Co. Ltd., Contec Medical Systems Co. Ltd., Bionet Co. Ltd., Analogic Corporation, Atom Medical Corporation, Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Cooper Surgical Inc., Dixion Vertrieb medizinischer Gerate GmbH, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, Huntleigh Healthcare Limited, Masimo Corporation, Mediana Co. Ltd., Mindray Medical International Limited, Nonin Medical Inc., OBMedical Company, PeriGen Inc., Sunray Medical Apparatus Co. Ltd.

North America was the largest region in the fetal monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global fetal monitoring market report forecast period. The regions covered in the fetal monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fetal monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The fetal monitoring market includes revenues earned by entities by providing continuous electronic fetal monitoring, central fetal monitoring and intermittent auscultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The fetal monitoring market also includes sales of tocodynamometer, fetal scalp electrode and intrauterine pressure catheter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fetal Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fetal monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for fetal monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fetal monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Fetal Monitoring Market Characteristics

3. Fetal Monitoring Market Trends And Strategies

4. Fetal Monitoring Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Fetal Monitoring Growth Analysis And Strategic Analysis Framework

6. Fetal Monitoring Market Segmentation

7. Fetal Monitoring Market Regional And Country Analysis

8. Asia-Pacific Fetal Monitoring Market

9. China Fetal Monitoring Market

10. India Fetal Monitoring Market

11. Japan Fetal Monitoring Market

12. Australia Fetal Monitoring Market

13. Indonesia Fetal Monitoring Market

14. South Korea Fetal Monitoring Market

15. Western Europe Fetal Monitoring Market

16. UK Fetal Monitoring Market

17. Germany Fetal Monitoring Market

18. France Fetal Monitoring Market

19. Italy Fetal Monitoring Market

20. Spain Fetal Monitoring Market

21. Eastern Europe Fetal Monitoring Market

22. Russia Fetal Monitoring Market

23. North America Fetal Monitoring Market

24. USA Fetal Monitoring Market

25. Canada Fetal Monitoring Market

26. South America Fetal Monitoring Market

27. Brazil Fetal Monitoring Market

28. Middle East Fetal Monitoring Market

29. Africa Fetal Monitoring Market

30. Fetal Monitoring Market Competitive Landscape And Company Profiles

31. Fetal Monitoring Market Other Major And Innovative Companies

32. Global Fetal Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fetal Monitoring Market

34. Recent Developments In The Fetal Monitoring Market

35. Fetal Monitoring Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â